Mycobacterium wolinskyi is a rapidly growing mycobacterium, first described in 1999 as a member of the group Mycobacterium smegmatis (Mycobacterium smegmatis, Mycobacterium wolinskyi and Mycobacterium goodii). Only 19 case reports all over the world have been described on literature, none of them in Brazil. On this report, it is described one case of infection after a mammoplasty procedure performed in a private health service in the county of Recife, Pernambuco, Brazil, in 2009. The mycobacteria specie was identified using biochemical tests and sequencing the specific gene rpoB. To treat the infection by Mycobacterium wolinskyi it was necessary to combine antibiotics for a long period of time associated with surgical procedures of the breast abscesses.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892610 | PMC |
| http://dx.doi.org/10.4081/idr.2013.e12 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
First report of uncommon mycobacteria in post LASIK keratitis: Mycobacterium wolinskyi.
J Ophthalmic Inflamm Infect
October 2024
Division of Ophthalmology, Department of Clinical Neurosciences, Geneva University Hospitals, Rue Alcide-Jentzer 22, Geneva, 1205, Switzerland.
Article Synopsis
- LASIK surgery is the most common type of refractive surgery but carries risks, including infectious keratitis, which can damage the cornea and lead to vision loss.
- The demand for LASIK is increasing, prompting the medical field to focus on preventing post-operative infections caused by various pathogens.
- This text discusses a rare case of keratitis post-LASIK surgery caused by Mycobacterium wolinskyi, highlighting its unique clinical and microbial traits and the treatment challenges it poses.
infection after breast augmentation: A case report and comprehensive review.
IJID Reg
June 2024
Department of Internal Medicine, Amphia Hospital, Breda, Netherlands.
Article Synopsis
- - A 26-year-old woman developed a surgical site infection following bilateral breast augmentation and was treated successfully on an outpatient basis.
- - Treatment involved the oral antibiotics cotrimoxazole and ciprofloxacin, allowing for the preservation of one breast prosthesis.
- - The report includes a review of all related infection cases listed in the PubMed database up to December 2023, focusing on various diagnostic and treatment methods.
Aldehyde Reductase Activity of Carboxylic Acid Reductases.
Chembiochem
April 2024
Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, 8010, Graz, Austria.
Carboxylic acid reductase enzymes (CARs) are well known for the reduction of a wide range of carboxylic acids to the respective aldehydes. One of the essential CAR domains - the reductase domain (R-domain) - was recently shown to catalyze the standalone reduction of carbonyls, including aldehydes, which are typically considered to be the final product of carboxylic acid reduction by CAR. We discovered that the respective full-length CARs were equally able to reduce aldehydes.
View Article and Find Full Text PDFCatheter-related bloodstream Mycobacterium wolinskyi infection in an umbilical cord blood transplant recipient: a case report.
BMC Infect Dis
June 2022
Department of Infectious Diseases, Kameda Medical Center, Kamogawa, Chiba, Japan.
Background: Catheter-related bloodstream infection (CRBSI), caused by rapidly growing mycobacteria (RGM), is a rare infectious complication in hematopoietic stem cell transplant (HSCT) recipients and can often be misdiagnosed as Gram-positive rod (GPR) bacteremia.
Case Presentation: We present a case of CRBSI caused by Mycobacterium wolinskyi, a rare RGM, in a 44-year-old female patient who received an umbilical cord blood transplant.
Conclusions: Rapidly growing mycobacteria can stain as GPRs and may grow in routine blood culture media after 3-4 days of incubation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!